Understanding ADHD: How it Affects the Brain and Methods of Treatment

This material delves into the intricacies of attention-deficit/hyperactivity disorder (ADHD), explaining how it impacts executive functioning and various regions of the brain. It covers the genetic and biochemical markers of ADHD, diagnostic criteria, and the efficacy of medications and behavioral therapies in improving ADHD symptoms and overall quality of life.

Georgia, Jul 28 (The Conversation)—“My brain has way too many tabs open.” This self-reflective question is common for people with attention-deficit/hyperactivity disorder, or ADHD, a condition that dramatically impacts executive functioning. As a family nurse practitioner, I have diagnosed and treated many patients with ADHD and was diagnosed myself at 21.

Research shows several brain differences in those with ADHD. It primarily affects the prefrontal cortex, basal ganglia, and cerebellum, crucial areas for regulating attention, executive function, motor activity, and impulse control. Lower levels of neurotransmitters like dopamine and norepinephrine in these regions contribute to the symptoms seen in ADHD patients.

Diagnosing ADHD involves identifying persistent symptoms detrimental across various settings, not explained by other conditions. Effective treatments include stimulant and nonstimulant medications, combined with behavioral therapies and positive parenting strategies, which significantly improve outcomes and quality of life for affected individuals.